Fool.com
The World's Greatest Investing Community
Results 21 - 30 of 297 : Previous 1 2 3 4 5 6 7 8 9 Next
It can pay to catch rising stars.
Warning: Potential Blockbuster Ahead
It'll enter a crowded market, but there's plenty to go around.
Here We Go Again With Possible Side Effects
Merck is the newest victim.
The company gets a great deal from AstraZeneca.
Here Come the Swine Flu Vaccines
One step closer to injections.
And no drug to fix it.
Thinning Out Plavix's Monopoly
Another competitor's on the way.
Now Is the Time to Invest and Get Rich
Or is it?
Cost-cutting and revenue growth make WuXi a looker for the year.
Stick with these winners even after you quit.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK